Responses to COVID-19 from Dow Life Sciences | AIChE

Responses to COVID-19 from Dow Life Sciences


Conference Presentation

Conference Type

AIChE Annual Meeting

Presentation Date

November 19, 2020


9 minutes

Skill Level




Dow Life Sciences is a strategic market segment in Dow. The goal of this market segment is to deliver high quality product and technical solutions to Human Health and Human Comfort. There are 5 sub-platforms that we are participating in: API and Manufacturing, Topical Drugs, Oral Drugs, Biopharmaceutical, and medical devices. Dow products sold in this area include Carbowax Sentry PEGs, Isopropanol, defoamers etc. Under this challenging COVID-19 scenario, our Life Sciences global team, quickly responded by identifying unmet needs from the market and customers. Due to the high demand of isopropanol (IPA), the first response was to address the supply issue. This resulted in a capacity expansion of IPA. Meanwhile, we also coordinated the IPA supply among various pharmaceutical customers and continued supporting our strategic customers to launch drug products. In addition to IPA, our global team also captured opportunities related to other Dow products such as amines, chelants, and PEGs to support our global pharma customers in formulated hand sanitizers. Meanwhile, some disruptive opportunities were also identified and investigated due to a great effort and collaboration across Dow multiple functions.


Once the content has been viewed and you have attested to it, you will be able to download and print a certificate for PDH credits. If you have already viewed this content, please click here to login.




Do you already own this?



AIChE Member Credits 0.5
AIChE Pro Members $19.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
AIChE Explorer Members $29.00
Non-Members $29.00